High Court Won't Hear 'Reverse Payment' Challenge
The U.S. Supreme Court on Monday declined to take up a high-profile antitrust challenge to reverse payments, denying a certiorari petition after Bayer AG and generic-drug makers struck a deal that...To view the full article, register now.
Already a subscriber? Click here to view full article